{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:43:33Z","timestamp":1753875813698,"version":"3.41.2"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"State Key Lab of Microbial Metabolism and Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University","award":["YG2017ZD14"],"award-info":[{"award-number":["YG2017ZD14"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61503244","61832019"],"award-info":[{"award-number":["61503244","61832019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Area","award":["2016YFA0501703"],"award-info":[{"award-number":["2016YFA0501703"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: The most frequently mutated gene pairs in pancreatic adenocarcinoma (PAAD) are KRAS and TP53, and our goal is to illustrate the multiomics and molecular dynamics landscapes of KRAS\/TP53 mutation and also to obtain prospective novel drugs for KRAS- and TP53-mutated PAAD patients. Moreover, we also made an attempt to discover the probable link amid KRAS and TP53 on the basis of the abovementioned multiomics data. Method: We utilized TCGA &amp; Cancer Cell Line Encyclopedia data for the analysis of KRAS\/TP53 mutation in a multiomics manner. In addition to that, we performed molecular dynamics analysis of KRAS and TP53 to produce mechanistic descriptions of particular mutations and carcinogenesis. Result: We discover that there is a significant difference in the genomics, transcriptomics, methylomics, and molecular dynamics pattern of KRAS and TP53 mutation from the matching wild type in PAAD, and the prognosis of pancreatic cancer is directly linked with a particular mutation of KRAS and protein stability. Screened drugs are potentially effective in PAAD patients. Conclusions: KRAS and TP53 prognosis of PAAD is directly associated with a specific mutation of KRAS. Irinotecan and vandetanib are prospective drugs for PAAD patients with KRASG12Dmutation and TP53 mutation.<\/jats:p>","DOI":"10.1093\/bib\/bbaa149","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T19:10:36Z","timestamp":1592248236000},"source":"Crossref","is-referenced-by-count":22,"title":["Irinotecan and vandetanib create synergies for treatment of pancreatic cancer patients with concomitant TP53 and KRAS mutations"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-0970","authenticated-orcid":false,"given":"Aman Chandra","family":"Kaushik","sequence":"first","affiliation":[{"name":"School of Medicine, Jiangnan University, Wuxi, China"}]},{"given":"Yan-Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Life Sciences and Biotechnology, Shanghai Jiao Tong University"}]},{"given":"Xiangeng","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Life Sciences and Biotechnology, Shanghai Jiao Tong University"}]},{"given":"Dong-Qing","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Life Sciences and Biotechnology, Shanghai Jiao Tong University"}]}],"member":"286","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"2021052110185231500_ref1","first-page":"7","article-title":"Cancer statistics","author":"Siegel","year":"2017"},{"key":"2021052110185231500_ref2","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"2021052110185231500_ref3","first-page":"1691","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume-title":"N Engl J Med","author":"Von Hoff","year":"2013"},{"key":"2021052110185231500_ref4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"2021052110185231500_ref5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/SLA.0000000000001763","article-title":"Multi-institutional validation study of the American joint commission on cancer changes for T and N staging in patients with pancreatic adenocarcinoma","volume":"265","author":"Allen","year":"2017","journal-title":"Ann Surg"},{"key":"2021052110185231500_ref6","doi-asserted-by":"crossref","first-page":"e105631","DOI":"10.1371\/journal.pone.0105631","article-title":"A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest","volume":"9","author":"Newhook","year":"2014","journal-title":"PloS One"},{"key":"2021052110185231500_ref7","doi-asserted-by":"crossref","first-page":"e0133562","DOI":"10.1371\/journal.pone.0133562","article-title":"Prognostic fifteen-gene signature for early stage pancreatic ductal adenocarcinoma","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"2021052110185231500_ref8","doi-asserted-by":"crossref","first-page":"e1000307","DOI":"10.1371\/journal.pmed.1000307","article-title":"A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma","volume":"7","author":"Stratford","year":"2010","journal-title":"PLoS Med"},{"key":"2021052110185231500_ref9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13073-014-0105-3","article-title":"A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma","volume":"6","author":"Haider","year":"2014","journal-title":"Genome Med"},{"key":"2021052110185231500_ref10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc3721","article-title":"Principles and methods of integrative genomic analyses in cancer","volume":"14","author":"Kristensen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2021052110185231500_ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"2021052110185231500_ref12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","article-title":"Perturbation-response genes reveal signaling footprints in cancer gene expression","volume":"9","author":"Schubert","year":"2018","journal-title":"Nat Commun"},{"key":"2021052110185231500_ref13","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","article-title":"Pi3k-pkb\/akt pathway","volume":"4","author":"Hemmings","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2021052110185231500_ref14","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/294097","article-title":"Crosstalk between p53 and TGF-\u03b2 signalling","volume":"2012","author":"Elston","year":"2012","journal-title":"J Signal Transduction"},{"key":"2021052110185231500_ref15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.coph.2010.05.010","article-title":"MiRNAs as biomarkers and therapeutic targets in cancer","volume":"10","author":"Heneghan","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"2021052110185231500_ref16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2021052110185231500_ref17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021052110185231500_ref18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/BJ20091888","article-title":"Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights","volume":"427","author":"Merabet","year":"2010","journal-title":"Biochem J"},{"key":"2021052110185231500_ref19","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1038\/sj.onc.1204934","article-title":"The 'wildtype' conformation of p53: epitope mapping using hybrid proteins (vol 20, pg 2318, 2001)","volume":"20","author":"Wang","year":"2001","journal-title":"Oncogene"},{"key":"2021052110185231500_ref20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1039\/c003915b","article-title":"The missing zinc: p53 misfolding and cancer","volume":"2","author":"Loh","year":"2010","journal-title":"Metallomics"},{"key":"2021052110185231500_ref21","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1021\/bi0603165","article-title":"Effect of Zn2+ on DNA recognition and stability of the p53 DNA-binding domain","volume":"45","author":"Duan","year":"2006","journal-title":"Biochemistry"},{"key":"2021052110185231500_ref22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/acs.biochem.7b00974","article-title":"KRAS switch mutants D33E and A59G crystallize in the state 1 conformation","volume":"57","author":"Lu","year":"2018","journal-title":"Biochemistry"},{"key":"2021052110185231500_ref23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1947601911412376","article-title":"Therapeutic strategies for targeting ras proteins","volume":"2","author":"Gysin","year":"2011","journal-title":"Genes Cancer"},{"key":"2021052110185231500_ref24","doi-asserted-by":"crossref","first-page":"6625","DOI":"10.1073\/pnas.1419895112","article-title":"Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site","volume":"112","author":"Mazhab-Jafari","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021052110185231500_ref25","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/1541-7786.MCR-15-0203","article-title":"Biochemical and structural analysis of common cancer-associated KRAS mutations","volume":"13","author":"Hunter","year":"2015","journal-title":"Mol Cancer Res"},{"key":"2021052110185231500_ref26","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2021052110185231500_ref27","doi-asserted-by":"crossref","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2021052110185231500_ref28","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"2021052110185231500_ref29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2021052110185231500_ref30","first-page":"61","volume-title":"Pheatmap: Pretty Heatmaps. R Package Version","author":"Kolde","year":"2012"},{"key":"2021052110185231500_ref31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics: J Integr Biol"},{"key":"2021052110185231500_ref32","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/nar\/gku631","article-title":"The multiMiR R package and database: integration of microRNA\u2013target interactions along with their disease and drug associations","volume":"42","author":"Ru","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021052110185231500_ref33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"key":"2021052110185231500_ref34","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/bioinformatics\/btv723","article-title":"PharmacoGx: an R package for analysis of large pharmacogenomic datasets","volume":"32","author":"Smirnov","year":"2016","journal-title":"Bioinformatics"},{"key":"2021052110185231500_ref35","doi-asserted-by":"crossref","DOI":"10.4137\/CIN.S13495","article-title":"OmicCircos: a simple-to-use R package for the circular visualization of multidimensional omics data","volume":"13","author":"Hu","year":"2014","journal-title":"Cancer Inform"},{"key":"2021052110185231500_ref36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","article-title":"Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations","volume":"265","author":"Cho","year":"1994","journal-title":"Science"},{"key":"2021052110185231500_ref37","article-title":"In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C","volume":"111","author":"Hunter","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021052110185231500_ref38","doi-asserted-by":"crossref","first-page":"W665","DOI":"10.1093\/nar\/gkh381","article-title":"PDB2PQR: an automated pipeline for the setup of Poisson\u2013Boltzmann electrostatics calculations","volume":"32","author":"Dolinsky","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2021052110185231500_ref39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1097-0134(199602)24:2<227::AID-PROT9>3.0.CO;2-F","article-title":"Fitting an inhibitor into the active site of thermolysin: a molecular dynamics case study","volume":"24","author":"Wasserman","year":"1996","journal-title":"Proteins: Struct Funct Bioinf"},{"key":"2021052110185231500_ref40","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1021\/ja00168a021","article-title":"A new force field for modeling metalloproteins","volume":"112","author":"Vedani","year":"1990","journal-title":"J Am Chem Soc"},{"key":"2021052110185231500_ref41","doi-asserted-by":"crossref","first-page":"11538","DOI":"10.1021\/jp0742261","article-title":"Molecular dynamics simulations of p53 DNA-binding domain","volume":"111","author":"Lu","year":"2007","journal-title":"J Phys Chem B"},{"key":"2021052110185231500_ref42","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J Comput Chem"},{"key":"2021052110185231500_ref43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"key":"2021052110185231500_ref44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"key":"2021052110185231500_ref45","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1063\/1.470648","article-title":"Constant pressure molecular dynamics simulation: the Langevin piston method","volume":"103","author":"Feller","year":"1995","journal-title":"J Chem Phys"},{"key":"2021052110185231500_ref46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"2021052110185231500_ref47","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J Appl Phys"},{"key":"2021052110185231500_ref48","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"2021052110185231500_ref49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","article-title":"Essential dynamics of proteins","volume":"17","author":"Amadei","year":"1993","journal-title":"Proteins"},{"key":"2021052110185231500_ref50","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1021\/ja00007a054","article-title":"Investigation of domain structure in proteins via molecular dynamics simulation: application to HIV-1 protease dimer","volume":"113","author":"Swaminathan","year":"1991","journal-title":"J Am Chem Soc"},{"key":"2021052110185231500_ref51","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","article-title":"Bio3d: an R package for the comparative analysis of protein structures","volume":"22","author":"Grant","year":"2006","journal-title":"Bioinformatics"},{"volume-title":"CCP4 Newsletter on protein crystallography","author":"DeLano","key":"2021052110185231500_ref52"},{"issue":"33\u201338","key":"2021052110185231500_ref53","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"key":"2021052110185231500_ref54","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J Mol Graph Model"},{"key":"2021052110185231500_ref55","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1073\/pnas.0802879105","article-title":"Understanding ligand-based modulation of the Hsp90 molecular chaperone dynamics at atomic resolution","volume":"105","author":"Colombo","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021052110185231500_ref56","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"Open source drug discovery C, et\u00a0al. g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J Chem Inf Model"},{"key":"2021052110185231500_ref57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"The Lancet"},{"key":"2021052110185231500_ref58","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"2021052110185231500_ref59","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/ERC-15-0555","article-title":"Treatment of advanced thyroid cancer with targeted therapies: ten years of experience","volume":"23","author":"David","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2021052110185231500_ref60","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1158\/1078-0432.CCR-1100-03","article-title":"Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy","volume":"10","author":"Ciardiello","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2021052110185231500_ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27580-1","article-title":"Nano-particle mediated inhibition of Parkinson\u2019s disease using computational biology approach","volume":"8","author":"Kaushik","year":"2018","journal-title":"Sci Rep"},{"issue":"4","key":"2021052110185231500_ref62","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1007\/s12035-017-0546-y","article-title":"Deciphering the biochemical pathway and pharmacokinetic study of amyloid \u03b2eta-42 with superparamagnetic iron oxide nanoparticles (spions) using systems biology approach","volume":"55","author":"Kaushik","year":"2018","journal-title":"Mol Neurobiol"},{"key":"2021052110185231500_ref63","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fchem.2018.00023","article-title":"Structure based virtual screening studies to identify novel potential compounds for GPR142 and their relative dynamic analysis for study of type 2 diabetes","volume":"6","author":"Kaushik","year":"2018","journal-title":"Front Chem"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/3\/bbaa149\/37966205\/bbaa149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/3\/bbaa149\/37966205\/bbaa149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T10:21:09Z","timestamp":1621592469000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbaa149\/5879228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaa149","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"type":"print","value":"1467-5463"},{"type":"electronic","value":"1477-4054"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2020,7,31]]},"article-number":"bbaa149"}}